Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs

An economic analysis of poliovirus risk management policy options for 2013–2052

(2015) Radboud J. Duintjer Tebbens et al.   BMC INFECTIOUS DISEASES

Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: A systematic review and implications for polio eradication

(2015) Jean Guo et al.   VACCINE

Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative

(2015) Glynis Dunn et al.   PLoS Pathogens

An analysis and decision tool to measure cost benefit of newborn screening for severe combined immunodeficiency (SCID) and related T-cell lymphopenia

(2014) Vicki Modell et al.   IMMUNOLOGIC RESEARCH

Sequential Asymptomatic Enterovirus Infections in a Patient with Major Histocompatibility Complex Class II Primary Immunodeficiency: FIG 1

(2014) Nadia Driss et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Modeling the Potential Role of Inactivated Poliovirus Vaccine to Manage the Risks of Oral Poliovirus Vaccine Cessation

(2014) Radboud J. Duintjer Tebbens et al.   JOURNAL OF INFECTIOUS DISEASES

Vaccine-Derived Polioviruses

(2014) C. C. Burns et al.   JOURNAL OF INFECTIOUS DISEASES

Poliovirus Excretion Among Persons With Primary Immune Deficiency Disorders: Summary of a Seven-Country Study Series

(2014) Li Li et al.   JOURNAL OF INFECTIOUS DISEASES

Progress in the Development of Poliovirus Antiviral Agents and Their Essential Role in Reducing Risks That Threaten Eradication

(2014) M. A. McKinlay et al.   JOURNAL OF INFECTIOUS DISEASES

Modeling the Dynamics of Oral Poliovirus Vaccine Cessation

(2014) Kimberly M. Thompson et al.   JOURNAL OF INFECTIOUS DISEASES

Modeling Options to Manage Type 1 Wild Poliovirus Imported Into Israel in 2013

(2014) Dominika A. Kalkowska et al.   JOURNAL OF INFECTIOUS DISEASES

Insidious reintroduction of wild poliovirus into Israel, 2013

(2013) E Anis et al.   Eurosurveillance

National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication

(2013) Kimberly M Thompson et al.   Expert Review of Vaccines

Highly Divergent Type 2 and 3 Vaccine-Derived Polioviruses Isolated from Sewage in Tallinn, Estonia

(2013) Haider Al-Hello et al.   JOURNAL OF VIROLOGY

Characteristics of an Environmentally Monitored Prolonged Type 2 Vaccine Derived Poliovirus Shedding Episode that Stopped without Intervention

(2013) Tapani Hovi et al.   PLoS One

Review and Assessment of Poliovirus Immunity and Transmission: Synthesis of Knowledge Gaps and Identification of Research Needs

(2013) Radboud J. Duintjer Tebbens et al.   RISK ANALYSIS

Characterizing Poliovirus Transmission and Evolution: Insights from Modeling Experiences with Wild and Vaccine-Related Polioviruses

(2013) Radboud J. Duintjer Tebbens et al.   RISK ANALYSIS

High Susceptibility for Enterovirus Infection and Virus Excretion Features in Tunisian Patients with Primary Immunodeficiencies

(2012) Nadia Driss et al.   Clinical and Vaccine Immunology

Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation

(2012) Kimberly M Thompson et al.   Expert Review of Vaccines

Primary Immunodeficiency Diseases Worldwide: More Common than Generally Thought

(2012) Ahmed Aziz Bousfiha et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Expert Review on Poliovirus Immunity and Transmission

(2012) Radboud J. Duintjer Tebbens et al.   RISK ANALYSIS

Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri Lanka

(2012) Rajiva de Silva et al.   VACCINE

Isolation of poliovirus shedding following vaccination in children with antibody deficiency disorders

(2012) Nermeen M Galal et al.   Journal of Infection in Developing Countries

Role of environmental poliovirus surveillance in global polio eradication and beyond

(2011) T. HOVI et al.   EPIDEMIOLOGY AND INFECTION

Global study of primary immunodeficiency diseases (PI)—diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation

(2011) Vicki Modell et al.   IMMUNOLOGIC RESEARCH

Vaccine-Derived Poliomyelitis 12 Years after Infection in Minnesota

(2011) Aaron S. DeVries et al.   NEW ENGLAND JOURNAL OF MEDICINE

The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008

(2009) B. Gathmann et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Incidence and Temporal Trends of Primary Immunodeficiency: A Population-Based Cohort Study

(2009) Avni Y. Joshi et al.   MAYO CLINIC PROCEEDINGS

Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication

(2009) Philip Minor   VACCINE

Common variable immunodeficiency disorders: division into distinct clinical phenotypes

(2008) H. Chapel et al.   BLOOD